期刊文献+

红细胞分布宽度在常见心血管疾病诊疗中的应用进展 被引量:7

Clinical Application and Progress of Red Blood Cell Distribution Width in the Diagnosis and Treatment of Common Cardiovascular Diseases
下载PDF
导出
摘要 红细胞分布宽度(RDW)既往主要用于贫血的诊断和分类。近年来研究发现,RDW在高血压、冠状动脉粥样硬化性心脏病(冠心病)、急慢性心力衰竭、肺动脉高压及非选择性人群中均有不同程度的升高,且与病情轻重呈正相关,RDW升高对该组疾病的预后有独立预测作用。目前其确切作用机制尚未明确,主要与营养不良、神经内分泌系统激活、炎性反应、肾功能不全、肝淤血、肝功能障碍有关。但RDW不是特异性指标,间接反映了患者病情较重、一般情况差,故可用于估计病情和预后。 Red blood cell distribution width( RDW) was mainly used in diagnosing and classifying of anemia in the past. Resent studies revealed that RDW elevates at different levels in the patients with hypertension,coronary heart diseases,acute or chronic heart failure,pulmonary artery hypertension and in the nonselective population,which is positively related to the severity of the disease condition,therefore elevated RDW can independently predict the prognosis of this group of diseases. However,the exact mechanisms need further studies and elevated RDW is mainly relative with malnutrition,activation of the neuroendocrine system,inflammatory reaction,renal failure,hepatic congestion and dysfunction. But RDW is not a specific indicator,and it indirectly reflects a serious illness condition and poor general condition,which can be used to evaluate the condition and estimate the prognosis.
出处 《医学综述》 2015年第4期660-663,共4页 Medical Recapitulate
关键词 红细胞分布宽度 冠心病 心力衰竭 预后 全因病死率 Red blood cell distribution width Coronary heart diseases Heart failure Prognosis Allcause mortality
  • 相关文献

参考文献31

二级参考文献49

  • 1张新友,郝玉书,邵宗鸿,徐肇明,钱林生.骨髓增生异常综合征及其继发白血病的治疗[J].中华血液学杂志,1994,15(7):349-352. 被引量:13
  • 2Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the duke databank[J]. J Am Coll Cardiol, 2007,50 : 40-47.
  • 3Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease[J]. Circulation,2008,117 : 163-168.
  • 4Cantaro S, Piva E. Hematological and iron parameters to predict mortality in ESRD[J]. G Ital Nefrol, 2005,22:S135-139.
  • 5Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events[J]. N Engl J Med, 2001, 344: 1959-1965.
  • 6韩雅玲,栾波.女性心血管疾病的预防[M]//胡大一,马长生.心脏病学实践2004.北京:人民卫生出版社,2004:262-291.
  • 7Caramelo C, Justo S, Gil P. Anemia in heart failure: pathophysiology,pathogenesis,treatment and incognitae[J] Rev Esp Cardiol, 2007,60 : 848-860.
  • 8Wada M,Nagasawa H, Kurita K, et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci, 2007, 255 : 27-34.
  • 9Lippi G,Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med, 2009, 133 : 628-632.
  • 10Wilson PW,Pencina M, Jacques P, et al. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes, 2008, 1 : 92-97.

共引文献66

同被引文献46

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部